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When Hollywood tackles a medical issue, such as in the movie “Concussion”1, it is worth 
pausing to consider the issue at question. In practice, the terms concussion and mild traumatic 
brain injury (mTBI) are used interchangeably. However, for the 20% or so of patients 
demonstrating persisting neurocognitive dysfunction after concussion, there is nothing “mild” 
about it.  Furthermore, a history of multiple concussions is linked to increased risk of 
neurodegenerative disease, in particular, chronic traumatic encephalopathy (CTE)2; the subject 
of “Concussion”.  Nevertheless, despite Hollywood movies and endless news headlines, there 
remains remarkable confusion over the underlying cause of concussion. 
 
Contrary to the all too common animations illustrating the brain slamming back and forth inside 
the skull, the principal mechanical basis of concussion is head rotational acceleration3. A 
consequence of these rotational forces is rapid deformation of the brain resulting in tissue 
damage, particularly to vulnerable white matter axons.  During normal movement, axons can 
stretch to at least twice their resting length and relax back, unharmed.  However, very rapid 
stretching, such as occurs with concussion, results in components of the axon becoming stiffer, 
resulting in breakage of axonal microtubules; a pathology known as diffuse axonal injury (DAI). 
Intriguingly, computational modeling suggests that the viscoelastic “Achilles’ heel” in axons is 
the microtubule stabilizing protein tau4.   
 
A consequence of this microtubule damage is interruption of normal axonal transport, leading to 
protein accumulation in axonal swellings at sites of injury.  However, although axonal swelling is 
evidence of DAI, the vast majority of injured axons appear morphologically normal after TBI, 
even in severe cases. Nevertheless, for many of these normal-appearing axons there is 
dysregulation of sodium channels resulting in impaired action potential formation; a potential 
physiological substrate for the common symptoms of concussion, such as decreased 
processing speed, memory disturbance and loss of consciousness.  Accompanying this sodium 
influx is an increase in intra-axonal calcium, leading to activation of proteases and inevitable 
axonal degeneration5. As such, the so called “mild” injury of concussion can result in permanent 
axonal loss.  
 
The script for “Concussion”1 has the hero, Dr Omalu (played by Will Smith), proclaiming “I have 
found a disease that no one has ever seen.”  The reality is that CTE had been recognized for 
many decades before being “discovered” in former American Footballers.  In these earlier 
accounts, largely in former boxers, neuropathology examinations at autopsy described a range 
of abnormalities in tau and amyloid-beta contributing to “dementia puglistica”, or CTE2.   
Interestingly, accumulation of amyloid precursor protein (APP) in injured axons triggers amyloid-
beta genesis.  Further, axonal tau protein can become phosphorylated after TBI, leading to 
pathological aggregation.  Thus, DAI-associated proteins, namely tau and APP, are implicated 
in both the acute injury of concussion and also the late neurodegeneration of chronic traumatic 
encephalopathy.   
 
In truth, despite the Hollywood attention and increasing hyperbole regarding concussion and its 
long-term consequences, there remain remarkable knowledge gaps. Most notably, we are really 
only at the beginning of deciphering the underlying causes, one important candidate being DAI. 
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